IRF1 and inflammatory bowel disease: GSEA analysis was also performed, to compare the response of B6 and Irf1−/− AOM/DSS-treated mice with the public GSE4183 dataset37 containing the expression profiles of human IBD and colorectal cancer tissues, and healthy controls (Fig. 3C).